PNTG
$33.03
The Pennant Group, Inc.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursin...
Recent News
Auna S.A. Sees Strong Gains From Peru: More Upside on the Horizon
AUNA's Peru operations shine with double-digit revenue and EBITDA growth, driven by high-complexity care and expanded health plan reach.
1 Momentum Stock to Research Further and 2 We Ignore
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.
1 Growth Stock with Explosive Upside and 2 We Avoid
Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.
3 Reasons to Avoid PNTG and 1 Stock to Buy Instead
The Pennant Group has had an impressive run over the past six months as its shares have beaten the S&P 500 by 30%. The stock now trades at $34.03, marking a 33% gain. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Did Pennant’s Record 2025 Results and Cautious 2026 EBITDA Guidance Just Shift PNTG’s Investment Narrative?
The Pennant Group recently reported its fourth-quarter and full-year 2025 results, with sales rising to US$289.32 million for the quarter and US$947.71 million for the year, alongside higher net income and earnings per share, and issued 2026 revenue guidance in the range of US$1.13 billion to US$1.17 billion. Management’s 2026 outlook, including adjusted EBITDA guidance below analyst expectations despite record growth and large acquisitions such as Signature Healthcare at Home and former...